Lucid Diagnostics Q3 2026 Results: Net Loss of $6.68M, Loss Narrows
Lucid Diagnostics reported a net loss of $6.7 million for the quarter ended September 30, 2026, an improvement from the $10.4 million loss in the prior year period. Total revenue remained flat year-over-year at $1.2 million, while the company significantly reduced its total liabilities from $29.5 million at year-end 2025 to $21.9 million.
- Key figure
- Net loss $6.68M